Description
Semaglutide (GLP-1 SE) (10 mg) is supplied as a lyophilized powder in a Type I borosilicate glass vial sealed under vacuum. Semaglutide is a lyophilized GLP-1 receptor agonist research peptide studied in-vitro for incretin-pathway signaling.
Molecular formula C₁₈₇H₂₉₁N₄₅O₅₉, molecular weight 4,113.6 g/mol, sequence length 31 amino acids (CAS 910463-68-2).
Every production lot is synthesized in a validated cGMP-grade research facility and independently assayed by accredited third-party analytical laboratories using reverse-phase HPLC and mass spectrometry. Each vial is verified to ≥99.0% purity and shipped with a certificate of analysis tied to the unique vial code printed on the label.
Research Use Only. This product is sold strictly as a research chemical for in-vitro laboratory study by qualified researchers and institutional laboratories. Not for human consumption, therapeutic use, or administration of any kind. Not a drug, food, cosmetic, or dietary supplement.




